601 Elmwood Avenue, Rochester, NY 14642
Website: University of Rochester Medical Center – Wilmot Cancer Institute
Contact:
Amy Rovitelli
585-275-6753
Linked In
You Tube
University of Rochester Medical Center - Wilmot Cancer Institute
Trials at this location:
HCRN GU18-343
A Phase 2 Study of CAbozantinib in Combination With AtezolizumaB as NeoAdjuvant Treatment for Muscle-Invasive BladdEr Cancer (ABATE)
Status: Open to Accrual
HCRN GU14-182
A Randomized, Double-Blinded, Phase II Study of Maintenance Pembrolizumab versus Placebo after First-line Chemotherapy in Patients with Metastatic Urothelial Cancer: HCRN GU14-182
Status: Closed to Accrual
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter